Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Russell J Butterfield

Showing results (51-60 of 73) with videos related to

Pageof 8
Sort By:
Plos One|October 19, 2020
Medical management of muscle weakness in Duchenne muscular dystrophySarah R Rivera, Sumit K Jhamb, Hoda Z Abdel-Hamid, et al.
Neuromuscular Disorders : NMD|February 20, 2025
Strength and functional correlates of reachable workspace in facioscapulohumeral muscular dystrophyLeo H Wang, Maya N Hatch, Michael P McDermott, et al.
Muscle & Nerve|November 5, 2020
Association of genetic mutations and loss of ambulation in childhood-onset dystrophinopathyGregory Haber, Kristin M Conway, Pangaja Paramsothy, et al.
Neuromuscular Disorders : NMD|July 3, 2023
Lean tissue mass measurements by dual-energy X-ray absorptiometry and associations with strength and functional outcome measures in facioscapulohumeral muscular dystrophyLeo H Wang, Doris G Leung, Kathryn R Wagner, et al.
Neuromuscular Disorders : NMD|March 20, 2026
Late-onset facioscapulohumeral muscular dystrophy defines a distinct clinical subgroupGiulia Tammam, Sandra Dhifallah, Hongmei Yang, et al.
Neurology. Genetics|May 2, 2019
Clinical, genetic, and pathologic characterization of <i>FKRP</i> Mexican founder mutation c.1387A>GAngela J Lee, Karra A Jones, Russell J Butterfield, et al.
Neurology|May 11, 2022
Randomized Phase 2 Study of ACE-083 in Patients With Charcot-Marie-Tooth DiseaseFlorian P Thomas, Thomas H Brannagan, Russell J Butterfield, et al.
Human Mutation|September 11, 2014
Mosaicism for dominant collagen 6 mutations as a cause for intrafamilial phenotypic variabilitySandra Donkervoort, Ying Hu, Tanya Stojkovic, et al.
Neuromuscular Disorders : NMD|June 12, 2020
Randomized phase 2 trial and open-label extension of domagrozumab in Duchenne muscular dystrophyKathryn R Wagner, Hoda Z Abdel-Hamid, Jean K Mah, et al.
BMC Medical Genomics|November 14, 2025
RNA sequencing provides functional insights and diagnostic resolution in previously unsolved rare disease casesRobert G Lewis, John M O'Shea, Lucilla Pizzo, et al.
Pageof 8

Showing results (51-60 of 73) with videos related to

Sort By:
Pageof 8
Plos One|October 19, 2020
Medical management of muscle weakness in Duchenne muscular dystrophySarah R Rivera, Sumit K Jhamb, Hoda Z Abdel-Hamid, et al.
Neuromuscular Disorders : NMD|February 20, 2025
Strength and functional correlates of reachable workspace in facioscapulohumeral muscular dystrophyLeo H Wang, Maya N Hatch, Michael P McDermott, et al.
Muscle & Nerve|November 5, 2020
Association of genetic mutations and loss of ambulation in childhood-onset dystrophinopathyGregory Haber, Kristin M Conway, Pangaja Paramsothy, et al.
Neuromuscular Disorders : NMD|July 3, 2023
Lean tissue mass measurements by dual-energy X-ray absorptiometry and associations with strength and functional outcome measures in facioscapulohumeral muscular dystrophyLeo H Wang, Doris G Leung, Kathryn R Wagner, et al.
Neuromuscular Disorders : NMD|March 20, 2026
Late-onset facioscapulohumeral muscular dystrophy defines a distinct clinical subgroupGiulia Tammam, Sandra Dhifallah, Hongmei Yang, et al.
Neurology. Genetics|May 2, 2019
Clinical, genetic, and pathologic characterization of <i>FKRP</i> Mexican founder mutation c.1387A>GAngela J Lee, Karra A Jones, Russell J Butterfield, et al.
Neurology|May 11, 2022
Randomized Phase 2 Study of ACE-083 in Patients With Charcot-Marie-Tooth DiseaseFlorian P Thomas, Thomas H Brannagan, Russell J Butterfield, et al.
Human Mutation|September 11, 2014
Mosaicism for dominant collagen 6 mutations as a cause for intrafamilial phenotypic variabilitySandra Donkervoort, Ying Hu, Tanya Stojkovic, et al.
Neuromuscular Disorders : NMD|June 12, 2020
Randomized phase 2 trial and open-label extension of domagrozumab in Duchenne muscular dystrophyKathryn R Wagner, Hoda Z Abdel-Hamid, Jean K Mah, et al.
BMC Medical Genomics|November 14, 2025
RNA sequencing provides functional insights and diagnostic resolution in previously unsolved rare disease casesRobert G Lewis, John M O'Shea, Lucilla Pizzo, et al.
Pageof 8